Novo Nordisk’s blockbuster GLP-1 diabetes drug Ozempic led to improvements in some measures of alcohol use disorder in a small trial, researchers reported on Wednesday. The 48 participants in the nine ...
28 分钟
East Idaho News on MSNOzempic shown to reduce drinking in first trial in alcohol-use disorderFor years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果